IN2012DN01434A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01434A IN2012DN01434A IN1434DEN2012A IN2012DN01434A IN 2012DN01434 A IN2012DN01434 A IN 2012DN01434A IN 1434DEN2012 A IN1434DEN2012 A IN 1434DEN2012A IN 2012DN01434 A IN2012DN01434 A IN 2012DN01434A
- Authority
- IN
- India
- Prior art keywords
- tramadol
- celecoxib
- analgesics
- medicaments
- severe
- Prior art date
Links
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 abstract 1
- 229960000590 celecoxib Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960004380 tramadol Drugs 0.000 abstract 1
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09384004A EP2311446A1 (en) | 2009-10-16 | 2009-10-16 | Compositions comprising Tramadol and Celecoxib in the treatment of pain |
PCT/EP2010/006317 WO2011045075A1 (en) | 2009-10-16 | 2010-10-15 | Compositions comprising tramadol and celecoxib in the treatment of pain |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN01434A true IN2012DN01434A (ko) | 2015-06-05 |
Family
ID=41566149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1434DEN2012 IN2012DN01434A (ko) | 2009-10-16 | 2010-10-15 |
Country Status (34)
Country | Link |
---|---|
US (3) | US8569271B2 (ko) |
EP (3) | EP2311446A1 (ko) |
JP (2) | JP5579858B2 (ko) |
KR (1) | KR101688996B1 (ko) |
CN (2) | CN102573824A (ko) |
AR (1) | AR078653A1 (ko) |
AU (1) | AU2010306114B2 (ko) |
BR (1) | BR112012005044B8 (ko) |
CA (1) | CA2771651C (ko) |
CO (1) | CO6511249A2 (ko) |
CY (1) | CY1114960T1 (ko) |
DK (1) | DK2488170T3 (ko) |
EC (1) | ECSP12011735A (ko) |
ES (1) | ES2450615T3 (ko) |
HK (1) | HK1173379A1 (ko) |
HR (1) | HRP20140157T1 (ko) |
IL (1) | IL218096A (ko) |
IN (1) | IN2012DN01434A (ko) |
MA (1) | MA33743B1 (ko) |
MX (1) | MX2012003051A (ko) |
MY (1) | MY156275A (ko) |
NZ (1) | NZ598361A (ko) |
PL (1) | PL2488170T3 (ko) |
PT (1) | PT2488170E (ko) |
RS (1) | RS53202B (ko) |
RU (2) | RU2012120087A (ko) |
SG (1) | SG178833A1 (ko) |
SI (1) | SI2488170T1 (ko) |
SM (1) | SMT201400035B (ko) |
TN (1) | TN2012000059A1 (ko) |
TW (1) | TWI466668B (ko) |
UA (1) | UA108213C2 (ko) |
WO (1) | WO2011045075A1 (ko) |
ZA (1) | ZA201202151B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2177215A1 (en) | 2008-10-17 | 2010-04-21 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of tramadol and NSAIDs |
US8746719B2 (en) | 2010-08-03 | 2014-06-10 | Polaris Industries Inc. | Side-by-side vehicle |
EP3799866A1 (en) * | 2011-04-05 | 2021-04-07 | Optosolve Research & Development Ltd | Ophthalmic treatments comprising tramadol |
US20130203783A1 (en) * | 2012-02-06 | 2013-08-08 | William L. Pridgen | Valaciclovir and celecoxib combination therapy for functional somatic syndromes |
WO2016116942A1 (en) | 2015-01-20 | 2016-07-28 | Anlon Chemical Research Organization | Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin |
AU2016267685A1 (en) * | 2015-05-28 | 2017-12-07 | Dr. Reddy's Laboratories Ltd. | Oral composition of celecoxib for treatment of pain |
KR101710792B1 (ko) | 2015-07-14 | 2017-02-28 | 주식회사 유영제약 | 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물 |
MX2016006464A (es) * | 2016-05-18 | 2017-11-17 | Laboratorios Liomont S A De C V | Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor. |
BR112018074486A2 (pt) * | 2016-05-27 | 2019-05-28 | Dr Reddy´S Laboratories Ltd | composição oral de celecoxib para tratamento da dor |
WO2018186650A2 (ko) * | 2017-04-03 | 2018-10-11 | 주식회사 킴스헬스케어 | 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제 |
KR102033716B1 (ko) | 2017-04-03 | 2019-10-17 | 주식회사 킴스헬스케어 | 트라마돌과 셀레콕시브를 포함한 경구투여용 이중 복합정제 |
KR102631399B1 (ko) | 2018-03-30 | 2024-02-01 | 씨지인바이츠 주식회사 | 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물 |
CN113825501A (zh) * | 2019-05-14 | 2021-12-21 | 埃斯蒂文制药股份有限公司 | 曲马多和塞来昔布的共晶体用于治疗疼痛同时降低曲马多的滥用倾向的用途 |
CN112007024A (zh) * | 2019-05-28 | 2020-12-01 | 江苏恒瑞医药股份有限公司 | 艾瑞昔布与曲马多联合在制备治疗疼痛的药物中的用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516803A (en) | 1991-10-30 | 1996-05-14 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
AU661723B2 (en) | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
RS49982B (sr) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
MXPA01008903A (es) * | 1999-03-01 | 2003-07-21 | Johnson & Jonhson | Composicion que comprende un material de tramadol y un farmaco inhibidor de cox-2 selectivo. |
DE19927688A1 (de) | 1999-06-17 | 2000-12-21 | Gruenenthal Gmbh | Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
PT1478366E (pt) * | 2002-02-19 | 2009-03-10 | Adcock Ingram Ltd | Combinações farmacêuticas de meloxicam, fosfato de codeína e paracetamol |
US20080031950A1 (en) * | 2007-04-27 | 2008-02-07 | Nectid Inc. | Novel anelgesic combination |
CA2771665C (en) * | 2009-10-16 | 2015-10-06 | Laboratorios Del Dr. Esteve, S.A. | Co-crystals of tramadol and coxibs |
EP2392319A1 (en) * | 2010-06-04 | 2011-12-07 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
-
2009
- 2009-10-16 EP EP09384004A patent/EP2311446A1/en not_active Withdrawn
-
2010
- 2010-10-14 TW TW99134996A patent/TWI466668B/zh active
- 2010-10-15 WO PCT/EP2010/006317 patent/WO2011045075A1/en active Application Filing
- 2010-10-15 RU RU2012120087/15A patent/RU2012120087A/ru unknown
- 2010-10-15 RU RU2016125895A patent/RU2707752C2/ru active
- 2010-10-15 AU AU2010306114A patent/AU2010306114B2/en active Active
- 2010-10-15 JP JP2012533530A patent/JP5579858B2/ja active Active
- 2010-10-15 MY MYPI2012000614A patent/MY156275A/en unknown
- 2010-10-15 UA UAA201205897A patent/UA108213C2/uk unknown
- 2010-10-15 EP EP10765762.9A patent/EP2488170B1/en active Active
- 2010-10-15 US US13/394,995 patent/US8569271B2/en active Active
- 2010-10-15 PT PT107657629T patent/PT2488170E/pt unknown
- 2010-10-15 AR ARP100103776A patent/AR078653A1/es not_active Application Discontinuation
- 2010-10-15 CN CN2010800463605A patent/CN102573824A/zh active Pending
- 2010-10-15 PL PL10765762T patent/PL2488170T3/pl unknown
- 2010-10-15 BR BR112012005044A patent/BR112012005044B8/pt active IP Right Grant
- 2010-10-15 DK DK10765762.9T patent/DK2488170T3/en active
- 2010-10-15 RS RS20140100A patent/RS53202B/en unknown
- 2010-10-15 CA CA2771651A patent/CA2771651C/en active Active
- 2010-10-15 EP EP13005822.5A patent/EP2737898A1/en not_active Withdrawn
- 2010-10-15 KR KR1020127009600A patent/KR101688996B1/ko active IP Right Review Request
- 2010-10-15 CN CN201611195215.9A patent/CN107050006A/zh active Pending
- 2010-10-15 NZ NZ598361A patent/NZ598361A/en unknown
- 2010-10-15 SI SI201030545T patent/SI2488170T1/sl unknown
- 2010-10-15 IN IN1434DEN2012 patent/IN2012DN01434A/en unknown
- 2010-10-15 MX MX2012003051A patent/MX2012003051A/es active IP Right Grant
- 2010-10-15 SG SG2012010898A patent/SG178833A1/en unknown
- 2010-10-15 ES ES10765762.9T patent/ES2450615T3/es active Active
-
2012
- 2012-02-10 TN TNP2012000059A patent/TN2012000059A1/en unknown
- 2012-02-14 IL IL218096A patent/IL218096A/en active IP Right Grant
- 2012-03-16 CO CO12046133A patent/CO6511249A2/es active IP Right Grant
- 2012-03-19 EC ECSP12011735 patent/ECSP12011735A/es unknown
- 2012-03-23 ZA ZA2012/02151A patent/ZA201202151B/en unknown
- 2012-05-11 MA MA34860A patent/MA33743B1/fr unknown
-
2013
- 2013-01-17 HK HK13100719.5A patent/HK1173379A1/xx unknown
- 2013-09-25 US US14/036,828 patent/US20140024622A1/en not_active Abandoned
-
2014
- 2014-02-19 HR HRP20140157AT patent/HRP20140157T1/hr unknown
- 2014-03-10 CY CY20141100195T patent/CY1114960T1/el unknown
- 2014-03-20 SM SM201400035T patent/SMT201400035B/xx unknown
- 2014-07-09 JP JP2014141720A patent/JP2014221797A/ja not_active Withdrawn
-
2015
- 2015-02-04 US US14/613,475 patent/US20150150889A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN01434A (ko) | ||
UA109661C2 (uk) | Фармацевтична композиція співкристалів трамадолу і коксибів | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
IN2012DN02805A (ko) | ||
WO2012088266A3 (en) | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 | |
MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
WO2012055567A3 (en) | Use of malononitrilamides in neuropathic pain | |
EP4233545A3 (en) | Synergistic bacterial compositions and methods of production and use thereof | |
HK1133787A1 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
NZ608116A (en) | Triazine-oxadiazoles | |
EP2528603A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS | |
MX2011011950A (es) | Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas. | |
MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
MX2012007806A (es) | Composiciones farmaceuticas para administracion oral de peptidos de insulina. | |
MX2012004780A (es) | Inhibidores de akt. | |
IL210997A (en) | Preparations for the treatment of mrsa and their uses for the preparation of medicines | |
MX347734B (es) | Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas. | |
MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
MX2016006604A (es) | Derivados de piperidina con actividad multimodal contra el dolor. | |
GEP201606514B (en) | Apoptosis inhibitors and usage thereof | |
EP2576536A4 (en) | INHIBITORS OF HEMATOPOIETIC PROSTAGLANDIN D2 SYNTHASE | |
MX2016006603A (es) | Compuestos piperidinicos con actividad multimodal contra el dolor. | |
MX2012002580A (es) | Compuesto antibacteriano novedoso de hidroxifenilo. | |
MX337145B (es) | Composiciones farmaceuticas. | |
MY171941A (en) | Pharmaceutical compositions |